These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8867947)

  • 1. [Effect of cholestyramine on angiopathies in cholesterol-fed mice and diabetic mice].
    Sugiura M; Suenaga H; Kasuya Y; Kamata K
    J Smooth Muscle Res; 1995 Dec; 31(6):400-2. PubMed ID: 8867947
    [No Abstract]   [Full Text] [Related]  

  • 2. Ca2+ mobilization in the aortic endothelium in streptozotocin-induced diabetic and cholesterol-fed mice.
    Kamata K; Nakajima M
    Br J Pharmacol; 1998 Apr; 123(8):1509-16. PubMed ID: 9605555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of endothelium-dependent relaxation in cholesterol-fed and streptozotocin-induced diabetic mice by the chronic administration of cholestyramine.
    Kamata K; Sugiura M; Kojima S; Kasuya Y
    Br J Pharmacol; 1996 May; 118(2):385-91. PubMed ID: 8735642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pravastatin alone and in combination with low-dose cholestyramine in patients with primary hypercholesterolemia and coronary artery disease.
    Ito MK; Shabetai R
    Am J Cardiol; 1997 Sep; 80(6):799-802. PubMed ID: 9315597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DEAE-Dextran in the treatment of primary hypercholesterolemia and/or hypercholesterolemia combined with hypertriglyceridemia. A multicentric randomized study on the efficacy of DEAE-Dextran compared with Cholestyramine.
    Fedele F
    Clin Ter; 2003; 154(4):231-6. PubMed ID: 14618939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pravastatin in treatment of hypercholesterolemia in non-insulin-dependent diabetes patients.
    Soonthornpun S; Rattarasarn C; Leelawattana R; Thamprasit A
    J Med Assoc Thai; 1997 Jan; 80(1):9-15. PubMed ID: 9078811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
    Prescrire Int; 1999 Aug; 8(42):116-20. PubMed ID: 11503831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
    Gylling H; Miettinen TA
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI.
    Jolley CD; Dietschy JM; Turley SD
    Hepatology; 2000 Dec; 32(6):1309-16. PubMed ID: 11093738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on heart disease. Evidence mounts for even lower LDL.
    Clark WL
    Diabetes Self Manag; 2007; 24(1):29-30, 32. PubMed ID: 17283507
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of cholesterol reduction with cholestyramine on renal function.
    Kshirsagar AV; Shoham DA; Bang H; Hogan SL; Simpson RJ; Colindres RE
    Am J Kidney Dis; 2005 Nov; 46(5):812-9. PubMed ID: 16253720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment with pravastatin of dyslipidemia associated with diabetic nephropathy].
    Robles NR; Ruiz-Calero R; Coronado M; Escola JM; Sánchez Casado E
    An Med Interna; 1998 Nov; 15(11):572-5. PubMed ID: 9882852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perspectives on statins.
    Mishra TK; Routray S
    J Indian Med Assoc; 2003 Jun; 101(6):381-3. PubMed ID: 14579987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
    Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination therapy of hypercholesterolemia].
    Vanhanen H; Gylling H; Miettinen TA
    Duodecim; 2002; 118(19):1967-73. PubMed ID: 12462803
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine.
    Carrilho AJ; Medina WL; Nakandakare ER; Quintão EC
    Clin Pharmacol Ther; 1997 Jul; 62(1):82-8. PubMed ID: 9246022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nicotinic acid and lovastatin in combination with cholestyramine in renal transplant patients.
    Lal SM; Katyal A
    Mo Med; 2002; 99(10):580-4. PubMed ID: 12534147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of wheat fibre on the plasma cholesterol in rats.
    Kay RM; Truswell AS
    Proc Nutr Soc; 1975 May; 34(1):17A-18A. PubMed ID: 1144394
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypercholesterolemia in children.
    Shamir R; Lerner A; Fisher EA
    Isr Med Assoc J; 2000 Oct; 2(10):767-71. PubMed ID: 11344730
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of hypocholesteremic agents on the skin.
    Roe DA
    Geriatrics; 1966 Oct; 21(10):174-82. PubMed ID: 5922086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.